Literature DB >> 5006795

Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates.

S J Robboy, E J Lewis, P H Schur, R W Colman.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 5006795     DOI: 10.1016/s0002-9343(70)80056-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  16 in total

1.  The properties of immune complexes formed by human antibodies to factor VIII.

Authors:  J Lazarchick; L W Hoyer
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

2.  Pregnancy and antibody to factor VIII.

Authors:  J Voke; E Letsky
Journal:  J Clin Pathol       Date:  1977-10       Impact factor: 3.411

3.  Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL.

Authors:  R Wu; A K Lefvert
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

4.  IgG2 deficiency in a healthy blood donor. Concomitant lack of IgG2, IgA and IgE immunoglobulins and specific anti-carbohydrate antibodies.

Authors:  L Hammarström; C I Smith
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

5.  Direct antiglobulin reactions in Gambian children with P. falciparum malaria. III. Expression of IgG subclass determinants and genetic markers and association with anaemia.

Authors:  C A Facer
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

6.  IgG sub-class levels in healthy Irish adults--a population study.

Authors:  D J Reen; M B Murphy; A O'Connor; M X FitzGerald
Journal:  Ir J Med Sci       Date:  1981-09       Impact factor: 1.568

7.  IgG subclass distribution of antibodies against S. aureus teichoic acid and alpha-toxin in normal and immunodeficient donors.

Authors:  L Hammarström; M Granström; V Oxelius; M A Persson; C I Smith
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

8.  Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII.

Authors:  G R Milner; P J Holt; J Bottomley; J E Maciver
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

9.  Semi-quantitative assessment of anti-insulin total IgG and IgG sub-classes in insulin-immunized patients using a highly sensitive immunochemical micromethod.

Authors:  M Koch; C François-Gérard; F Sodoyez-Goffaux; J C Sodoyez
Journal:  Diabetologia       Date:  1986-10       Impact factor: 10.122

10.  Studies of complement activation and IgG subclass restriction of anti-thyroglobulin.

Authors:  T R Adler; G N Beall; J G Curd; D C Heiner; U K Sabharwal
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.